Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 147,614 | 78,000 | 127,933 | 78,360 | 60,228 |
| Depreciation Amortization | 98,945 | 47,081 | 246,003 | 193,061 | 133,958 |
| Accounts receivable | -125,740 | 43,957 | -120,579 | -111,058 | -33,723 |
| Other Working Capital | -381,590 | -190,082 | -204,516 | -192,226 | -141,488 |
| Other Operating Activity | 212,784 | -5,699 | 291,151 | 241,540 | 72,252 |
| Operating Cash Flow | $-47,987 | $-26,743 | $339,992 | $209,677 | $91,227 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -59,452 | -13,860 | -96,749 | -54,295 | -39,245 |
| Purchase Sale Intangibles | -85,000 | -7,850 | -15,514 | -12,514 | -5,100 |
| Other Investing Activity | -85,000 | -7,850 | -15,514 | -12,514 | -5,100 |
| Investing Cash Flow | $-144,452 | $-21,710 | $-112,263 | $-66,809 | $-44,345 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 218,000 | N/A |
| Debt Issued | 234,673 | 135,183 | 2,912,750 | 2,694,750 | 218,000 |
| Debt Repayment | -147,027 | -140,842 | -2,811,508 | -2,805,384 | -251,076 |
| Common Stock Issued | 80 | 38 | 1,960 | 1,407 | 754 |
| Other Financing Activity | -67,420 | -53,434 | -134,732 | -130,183 | -48,531 |
| Financing Cash Flow | $20,306 | $-59,055 | $-31,530 | $-21,410 | $-80,853 |
| Exchange Rate Effect | -1,187 | -1,023 | -1,680 | -1,471 | -777 |
| Beginning Cash Position | 312,939 | 312,939 | 118,420 | 118,420 | 118,420 |
| End Cash Position | 139,619 | 204,408 | 312,939 | 238,407 | 83,672 |
| Net Cash Flow | $-173,320 | $-108,531 | $194,519 | $119,987 | $-34,748 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,987 | -26,743 | 339,992 | 209,677 | 91,227 |
| Capital Expenditure | -59,452 | -13,860 | -98,843 | -55,674 | -40,624 |
| Free Cash Flow | -107,439 | -40,603 | 241,149 | 154,003 | 50,603 |